Rethinking dietary approaches for type 2 diabetes 27 March 2026 Our research impact Challenge For decades, dietary guidelines for type 2 diabetes focused on high-carbohydrate, low-fat diets. But it was clear that carbohydrate is the primary factor driving larger, more rapid and prolonged glucose response after meals and these traditional approaches often delivered only modest improvements in weight and blood glucose control. With type 2 diabetes rates continuing to rise, Professor Grant Brinkworth and his team set out to find better solutions. Bold idea It was time to challenge old assumptions. Professor Brinkworth was supported by Diabetes Australia to conduct clinical trials to test hypotheses and explore alternative dietary approaches for type 2 diabetes management. Impact Clinical trials showed that replacing some carbohydrates with protein and healthy (unsaturated) fats, combined with structured exercise, achieved sustained and clinically relevant weight loss, greater improvement in blood glucose management, and reduction in risk factors for heart disease compared to the traditional high-carbohydrate, low-fat diet approach. Long-term studies confirmed superior benefits for managing type 2 diabetes and reducing heart disease risk—without harming kidney or brain health. This evidence has influenced global understanding of diet for type 2 diabetes, helping to modify clinical practice guidelines and has informed the development of and access to real-world practical products and services that are being used by individuals living with, and at risk of, diabetes and their health professionals to improve lives. Professor Brinkworth was able to leverage the generous funding from Diabetes Australia and its donors to secure an additional $3.1 million in research funding to explore long-term health effects of these dietary strategies. Learn more about diabetes research and our research impact.
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Goods Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading